Cancer diagnostic companies Exact Sciences and Genomic Health are combining in a $2.8 billion a cash-and-stock deal.
Click here for original story, Cancer diagnostic firms to join in .8 billion deal
Source: Phys.org
Cancer diagnostic companies Exact Sciences and Genomic Health are combining in a $2.8 billion a cash-and-stock deal.
Click here for original story, Cancer diagnostic firms to join in .8 billion deal
Source: Phys.org